CY1112850T1 - Μεθοδος για την προληψη των χειρουργικων συμφυσεων - Google Patents

Μεθοδος για την προληψη των χειρουργικων συμφυσεων

Info

Publication number
CY1112850T1
CY1112850T1 CY20121100295T CY121100295T CY1112850T1 CY 1112850 T1 CY1112850 T1 CY 1112850T1 CY 20121100295 T CY20121100295 T CY 20121100295T CY 121100295 T CY121100295 T CY 121100295T CY 1112850 T1 CY1112850 T1 CY 1112850T1
Authority
CY
Cyprus
Prior art keywords
preventing surgical
tissue
biomaterial
preventing
surgical
Prior art date
Application number
CY20121100295T
Other languages
English (en)
Inventor
Nicholas B Oray
Daniel L Mooradian
Original Assignee
Synovis Life Technologies, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synovis Life Technologies, Inc filed Critical Synovis Life Technologies, Inc
Publication of CY1112850T1 publication Critical patent/CY1112850T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μία μέθοδο και σύνθεση για την πρόληψη χειρουργικών συμφύσεων κατά την διάρκεια της χειρουργικής. Οι επιφάνειες των ιστών και/ή τα χειρουργικά είδη που ενέχονται στην χειρουργική διαχωρίζονται από ένα βιοϋλικό που παρέχεται με την μορφή ενός μη-διασταυρούμενα συνδεδεμένου, αποκυτταροποιημένου και κεκαθαρμένου ιστού θηλαστικών (π.χ. περικάρδιο βοοειδών). Το βιοϋλικό αναστέλλει αποτελεσματικά την ίνωση, τον σχηματισμό ουλών, και τις χειρουργικές συμφύσεις, ενώ χρησιμεύει επίσης και ως ένα ικρίωμα για την ανακυτταροποίηση του σημείου του ιστού.
CY20121100295T 2003-01-17 2012-03-20 Μεθοδος για την προληψη των χειρουργικων συμφυσεων CY1112850T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/346,240 US7144588B2 (en) 2003-01-17 2003-01-17 Method of preventing surgical adhesions
EP04702483A EP1635731B1 (en) 2003-01-17 2004-01-15 Method of preventing surgical adhesions

Publications (1)

Publication Number Publication Date
CY1112850T1 true CY1112850T1 (el) 2016-02-10

Family

ID=32712096

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100295T CY1112850T1 (el) 2003-01-17 2012-03-20 Μεθοδος για την προληψη των χειρουργικων συμφυσεων

Country Status (11)

Country Link
US (1) US7144588B2 (el)
EP (1) EP1635731B1 (el)
AT (1) ATE537855T1 (el)
AU (1) AU2004207454B2 (el)
CA (1) CA2513640C (el)
CY (1) CY1112850T1 (el)
DK (1) DK1635731T3 (el)
ES (1) ES2384504T3 (el)
PT (1) PT1635731E (el)
SI (1) SI1635731T1 (el)
WO (1) WO2004066965A2 (el)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8016823B2 (en) 2003-01-18 2011-09-13 Tsunami Medtech, Llc Medical instrument and method of use
US7892229B2 (en) 2003-01-18 2011-02-22 Tsunami Medtech, Llc Medical instruments and techniques for treating pulmonary disorders
US6599526B2 (en) * 2000-08-18 2003-07-29 The University Of North Texas Health Science Center At Fort Worth Pericardial anti-adhesion patch
US7549987B2 (en) 2000-12-09 2009-06-23 Tsunami Medtech, Llc Thermotherapy device
US9433457B2 (en) 2000-12-09 2016-09-06 Tsunami Medtech, Llc Medical instruments and techniques for thermally-mediated therapies
US8444636B2 (en) 2001-12-07 2013-05-21 Tsunami Medtech, Llc Medical instrument and method of use
US20060047291A1 (en) * 2004-08-20 2006-03-02 Uptake Medical Corporation Non-foreign occlusion of an airway and lung collapse
BRPI0518437A2 (pt) 2004-11-16 2008-11-18 Brian Cran dispositivo e mÉtodo para tratamento de pulmço
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US20060251702A1 (en) * 2005-05-05 2006-11-09 Cook Biotech Incorporated Implantable materials and methods for inhibiting tissue adhesion formation
US20070032785A1 (en) 2005-08-03 2007-02-08 Jennifer Diederich Tissue evacuation device
US20070088391A1 (en) * 2005-10-18 2007-04-19 Cook Biotech Inc. Medical device with affixation means
US7993323B2 (en) 2006-11-13 2011-08-09 Uptake Medical Corp. High pressure and high temperature vapor catheters and systems
US8585645B2 (en) * 2006-11-13 2013-11-19 Uptake Medical Corp. Treatment with high temperature vapor
US20080241270A1 (en) * 2007-03-30 2008-10-02 Neal Robert A Fluid composition for inhibiting surgical adhesion formation and related method of production
EP2170198B1 (en) 2007-07-06 2015-04-15 Tsunami Medtech, LLC Medical system
DE602008006232D1 (de) 2007-08-23 2011-05-26 Aegea Medical Inc Uterus-therapiegerät
US8322335B2 (en) 2007-10-22 2012-12-04 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
BRPI0818239A2 (pt) 2007-10-22 2017-12-05 Uptake Medical Corp determinação de parâmetros de tratamento e distribuição de vapor específicos a um paciente
US20090163936A1 (en) * 2007-12-21 2009-06-25 Chunlin Yang Coated Tissue Engineering Scaffold
US9924992B2 (en) 2008-02-20 2018-03-27 Tsunami Medtech, Llc Medical system and method of use
EP2113262B1 (en) 2008-04-29 2013-11-06 Proxy Biomedical Limited A Tissue Repair Implant
US8721632B2 (en) 2008-09-09 2014-05-13 Tsunami Medtech, Llc Methods for delivering energy into a target tissue of a body
US8579888B2 (en) 2008-06-17 2013-11-12 Tsunami Medtech, Llc Medical probes for the treatment of blood vessels
DE112009002177B4 (de) * 2008-10-03 2018-01-11 Replication Medical, Inc. Blutgefäß-Schutzvorrichtung
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
CN102238920B (zh) 2008-10-06 2015-03-25 维兰德.K.沙马 用于组织消融的方法和装置
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US11284931B2 (en) 2009-02-03 2022-03-29 Tsunami Medtech, Llc Medical systems and methods for ablating and absorbing tissue
US8900223B2 (en) 2009-11-06 2014-12-02 Tsunami Medtech, Llc Tissue ablation systems and methods of use
US9161801B2 (en) 2009-12-30 2015-10-20 Tsunami Medtech, Llc Medical system and method of use
US9943353B2 (en) 2013-03-15 2018-04-17 Tsunami Medtech, Llc Medical system and method of use
US9743974B2 (en) 2010-11-09 2017-08-29 Aegea Medical Inc. Positioning method and apparatus for delivering vapor to the uterus
US9662060B2 (en) 2011-10-07 2017-05-30 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
EP3964151A3 (en) 2013-01-17 2022-03-30 Virender K. Sharma Apparatus for tissue ablation
CA2899713C (en) 2013-03-15 2022-07-19 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US9526602B1 (en) * 2013-03-15 2016-12-27 Anne Piche-Radley Method of applying adhesion barriers
EP3046952B1 (en) 2013-09-19 2021-05-12 Terumo Corporation Polymer particles
JP6641265B2 (ja) 2013-09-19 2020-02-05 マイクロベンション インコーポレイテッドＭｉｃｒｏｖｅｎｔｉｏｎ， Ｉｎｃ． ポリマーフィルム
US9782211B2 (en) 2013-10-01 2017-10-10 Uptake Medical Technology Inc. Preferential volume reduction of diseased segments of a heterogeneous lobe
US9688788B2 (en) 2013-11-08 2017-06-27 Terumo Corporation Polymer particles
CN106794031B (zh) 2014-05-22 2020-03-10 埃杰亚医疗公司 完整性测试方法及用于向子宫输送蒸气的装置
CN106794030B (zh) 2014-05-22 2019-09-03 埃杰亚医疗公司 用于执行子宫内膜消融术的系统和方法
US10485604B2 (en) 2014-12-02 2019-11-26 Uptake Medical Technology Inc. Vapor treatment of lung nodules and tumors
US10531906B2 (en) 2015-02-02 2020-01-14 Uptake Medical Technology Inc. Medical vapor generator
WO2016154592A1 (en) 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
US11331037B2 (en) 2016-02-19 2022-05-17 Aegea Medical Inc. Methods and apparatus for determining the integrity of a bodily cavity
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
KR102566112B1 (ko) 2016-09-28 2023-08-10 테루모 가부시키가이샤 중합체 입자
US11129673B2 (en) 2017-05-05 2021-09-28 Uptake Medical Technology Inc. Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD
US11344364B2 (en) 2017-09-07 2022-05-31 Uptake Medical Technology Inc. Screening method for a target nerve to ablate for the treatment of inflammatory lung disease
US11350988B2 (en) 2017-09-11 2022-06-07 Uptake Medical Technology Inc. Bronchoscopic multimodality lung tumor treatment
USD845467S1 (en) 2017-09-17 2019-04-09 Uptake Medical Technology Inc. Hand-piece for medical ablation catheter
US11419658B2 (en) 2017-11-06 2022-08-23 Uptake Medical Technology Inc. Method for treating emphysema with condensable thermal vapor
US11490946B2 (en) 2017-12-13 2022-11-08 Uptake Medical Technology Inc. Vapor ablation handpiece
US11806066B2 (en) 2018-06-01 2023-11-07 Santa Anna Tech Llc Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems
US11653927B2 (en) 2019-02-18 2023-05-23 Uptake Medical Technology Inc. Vapor ablation treatment of obstructive lung disease

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991184A (en) 1973-10-05 1976-11-09 Martin Kludas Agent for the care of skin
US5059211A (en) 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US5085629A (en) 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
DE3835237C1 (el) 1988-10-15 1989-12-28 B. Braun Melsungen Ag, 3508 Melsungen, De
US4915113A (en) 1988-12-16 1990-04-10 Bio-Vascular, Inc. Method and apparatus for monitoring the patency of vascular grafts
US5258021A (en) 1992-01-27 1993-11-02 Duran Carlos G Sigmoid valve annuloplasty ring
US5411965A (en) 1993-08-23 1995-05-02 Arizona Board Of Regents Use of delta opioid receptor antagonists to treat cocaine abuse
GB9400163D0 (en) 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
US5503638A (en) 1994-02-10 1996-04-02 Bio-Vascular, Inc. Soft tissue stapling buttress
AU2621295A (en) 1994-05-24 1995-12-18 Smith & Nephew Plc Intervertebral disc implant
US5783214A (en) 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
US5447922A (en) 1994-08-24 1995-09-05 Bristol-Myers Squibb Company α-phosphonosulfinic squalene synthetase inhibitors
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US5728152A (en) 1995-06-07 1998-03-17 St. Jude Medical, Inc. Bioresorbable heart valve support
BR9713182A (pt) 1996-08-28 1999-11-03 Procter & Gamble Amidas de ácido fosfìnico como inibidores de metalo protease de matriz
US6166184A (en) 1997-08-18 2000-12-26 Medtronic Inc. Process for making a bioprosthetic device
ES2172986T3 (es) 1998-03-23 2002-10-01 Bio Vascular Inc Implantes y proceso de preparacion.
WO2000016822A1 (en) * 1998-09-21 2000-03-30 The Brigham And Women's Hospital, Inc. Compositions and methods for tissue repair
US6312474B1 (en) 1999-09-15 2001-11-06 Bio-Vascular, Inc. Resorbable implant materials

Also Published As

Publication number Publication date
PT1635731E (pt) 2012-03-30
AU2004207454A1 (en) 2004-08-12
SI1635731T1 (sl) 2012-04-30
ES2384504T3 (es) 2012-07-06
US20040141956A1 (en) 2004-07-22
CA2513640A1 (en) 2004-08-12
US7144588B2 (en) 2006-12-05
DK1635731T3 (da) 2012-04-16
EP1635731A2 (en) 2006-03-22
EP1635731A4 (en) 2009-11-18
EP1635731B1 (en) 2011-12-21
WO2004066965A3 (en) 2006-01-05
CA2513640C (en) 2013-11-19
WO2004066965A2 (en) 2004-08-12
ATE537855T1 (de) 2012-01-15
AU2004207454B2 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
CY1112850T1 (el) Μεθοδος για την προληψη των χειρουργικων συμφυσεων
JP4197158B2 (ja) 天然に発生する生物学的に誘導されている材料による装置
NO20021229D0 (no) Benzamider og lignende inhibitorer for faktor Xa
CY1106003T1 (el) Παραγωγα του ν-βενζοϋλοουρεϊδο-κινναμωμικου οξεος, μεθοδος για την παρασκευη τους και η χρηση τους
ECSP045239A (es) Composicion de ziprasidona y controles sinteticos
BR9509994A (pt) Derivados heterocíclicos aromáticos como inibidores de enzimas
DK0987998T3 (da) Decellulering af væv
CY1108041T1 (el) Αναστολεις της rho-κινασης
DE60007079D1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
BR0113184A (pt) Implante artificial e processo para produzir o mesmo
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
WO2003062248A3 (en) N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
PT1200105E (pt) Factor viii modificado
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
WO2004039248A3 (en) Repairing or replacing tissues or organs
UY27255A1 (es) Derivados de mercaptoacetilamida , procedimiento para su preparacinn y su uso
EP1605752A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
ATE454910T1 (de) Zusammengesetzte strukturen mit hyaluronsäure und derivaten davon als neue knochensubstitute und transplantate
NO20051844L (no) Piperazinderivater og fremgangsmate for anvendelse derav.
CY1109013T1 (el) Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν
BR0310011A (pt) Composição para reparar tecido, métodos para fabricar a mesma, para preparar tecido e para reparar um defeito tecidual em um paciente, composição injetável para reparar tecido, método para fabricar a mesma, e, dispositivo para reparar tecido
EA200600440A1 (ru) 4-((феноксиалкил)тио)еноксиуксусные кислоты и их аналоги
EP1509250A4 (en) METHOD, COMPOSITIONS AND PRODUCTION OBJECTS FOR MODULATING BONE GROWTH
BR0011339A (pt) Composto, uso, e processo para preparar o mesmo, composição farmacêutica, e, método para tratar uma condição de doença mediada por metaloproteinase
ATE367374T1 (de) Sulphonsäurederivate von hydroxamsäuren und deren verwendung in medizinischen produkten